The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Opioids Commonly Prescribed for Gout Attacks

Opioids Commonly Prescribed for Gout Attacks

July 9, 2019 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Nearly three in 10 patients seeking care at the emergency department (ED) for acute gout will be discharged with a prescription for opioids, new research shows.

You Might Also Like
  • More Than a Third of U.S. Adults Prescribed Opioids in 2015
  • U.S. Agency Issues New Guidelines to Limit Chronic Use of Opioids
  • Most Seniors Won’t Abuse Opioids After Surgery

“Our study suggests a high use of prescription opioid in patients discharged from the ED with a diagnosis of gout, a condition that can be managed effectively with other medications,” Deepan S. Dalal, MD, of Brown University Warren Alpert School of Medicine, Providence, and colleagues write.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Steroids, non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine can reduce pain and inflammation from gout attacks, the authors note in Arthritis Care and Research, online July 3.1

“Despite the efficacy of conventional agents, empirical evidence suggests common use of opioid analgesics in gout management,” they add.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The authors looked at Lifespan Healthcare Systems data on 456 patients discharged from the ED or hospital after treatment of acute gout between 2015 and 2017. At discharge, 28.3% were prescribed an opioid, 79% had not been on opioid medications previously.

The average dose was 37.9 mg of morphine equivalent for a median eight days.

Opioid prescription type was available for 119 patients, including 81% prescribed oxycodone or combinations of oxycodone, 8% prescribed hydrocodone and 9% prescribed tramadol.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Patients prescribed opioids at discharge were more likely to have diabetes, hypertension and substance abuse, and were also more likely to be using opioids at the time of admission. Patients with polyarticular gout attacks were also more likely to receive opioids at discharge.

“In addition to regulatory changes, the burden of opioid prescription could be potentially reduced by creating prompts for providers in electronic record system to avoid prescribing opioids in opioid-naive patients OR using lower intensity and shorter duration of prescription,” Dr. Dalal and colleagues write.

“Future prospective studies assessing the reasons for prescription of opioids may provide further insight into strategies to reduce the burden of prescription opioids,” they add.

Dr. Dalal was not available for an interview by press time.


Reference

  1. Dalal DS, Mbuyi N, Shah I, et al. Prescription opioid use among acute gout patients discharged from the emergency department. Arthritis Care Res (Hoboken). 2019 Jul 2. [Epub ahead of print]

Filed Under: Conditions, Crystal Arthritis Tagged With: Arthritis Care & Research, Emergency Department, Gout, opioid, Pain, Pain Management

You Might Also Like:
  • More Than a Third of U.S. Adults Prescribed Opioids in 2015
  • U.S. Agency Issues New Guidelines to Limit Chronic Use of Opioids
  • Most Seniors Won’t Abuse Opioids After Surgery
  • Wal-Mart Launches Program to Safely Dispose of Unused Opioids

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)